Segment Information - Summary of Summarized Financial Information for the Company's Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information
Consolidated revenue	$ 64,977	$ 52,275	$ 181,059	$ 150,699
Total segment depreciation expense	393	225	1,066	563
Total segment amortization	741	625	2,153	1,858
Selling, general and administrative expense	31,963	12,730	90,117	35,120
Non-segment depreciation and amortization	1,134	850	3,219	2,421
Loss from operations	(20,097)	(2,157)	(56,872)	(5,026)
Operating segments
Segment Reporting Information
Consolidated revenue	64,977	52,275	181,059	150,699
Total segment direct costs	51,977	40,852	144,595	118,184
Total segment depreciation expense	317	265	852	534
Total segment amortization	741	626	2,153	1,859
Total segment operating income	11,942	10,532	33,459	30,122
Selling, general and administrative expense	31,963	12,730	90,117	35,120
Non-segment assets
Segment Reporting Information
Non-segment depreciation and amortization	76	(41)	214	28
Patient services | Operating segments
Segment Reporting Information
Consolidated revenue	44,627	32,967	118,793	92,375
Total segment direct costs	36,126	25,391	96,379	72,051
Total segment depreciation expense	316	181	848	447
Total segment amortization	688	573	1,995	1,701
Total segment operating income	7,497	6,822	19,571	18,176
Dispensary | Operating segments
Segment Reporting Information
Consolidated revenue	18,839	17,918	57,736	53,318
Total segment direct costs	15,738	15,279	47,816	45,639
Total segment depreciation expense	0	1	0	1
Total segment amortization	0	0	0	0
Total segment operating income	3,101	2,638	9,920	7,678
Clinical trials & other | Operating segments
Segment Reporting Information
Consolidated revenue	1,511	1,390	4,530	5,006
Total segment direct costs	113	182	400	494
Total segment depreciation expense	1	83	4	86
Total segment amortization	53	53	158	158
Total segment operating income	$ 1,344	$ 1,072	$ 3,968	$ 4,268